Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2018/0369409 TUMOR-SPECIFIC PAYLOAD DELIVERY AND IMMUNE ACTIVATION USING A HUMAN ANTIBODY TARGETING A HIGHLY SPECIFIC TUMOR...
This invention provides antibodies directed against a highly specific and previously unrecognized marker for cancerous cells. In certain embodiments an...
2018/0369408 CYCLODEXTRIN AND ANTIBODY-DRUG CONJUGATE FORMULATIONS
Disclosed are formulations, including both liquid and lyophilized formulations, comprising a benzodiazepine antibody-drug conjugate (ADC) and a cyclodextrin....
2018/0369407 IMMUNE CELL-TARGETED PARTICLES
The present disclosure provides particles with a polymeric core containing a pharmaceutically active agent; and an antibody fragment conjugated to the surface...
2018/0369406 ROR1 Antibody Immunoconjugates
Provided herein are immunoconjugates comprising an anti-ROR1 antibody or an antigen-fragment fragment thereof and a drug moiety. These immunoconjugates are...
2018/0369405 METHODS OF PRODUCING DRUG-CARRYING POLYMER SCAFFOLDS AND PROTEIN-POLYMER-DRUG CONJUGATES
The disclosure provides methods of synthesis of polymeric scaffolds, e.g., those useful for conjugating with a protein based recognition-molecule (PBRM) to...
2018/0369404 RECOMBINANT ADENOVIRUSES CARRYING TRANSGENES
Disclosed herein are recombinant adenoviruses with one or more nucleotide sequences inserted between two viral transcription units, formulations comprising the...
2018/0369403 LGR4 SPECIFIC MONOCLONAL ANTIBODIES AND METHODS OF THEIR USE
Isolated or recombinant anti-LGR4 monoclonal antibodies are provided. In some cases, antibodies of the embodiments can be used for the detection, diagnosis...
2018/0369402 CONJUGATES OF TUMOR NECROSIS FACTOR INHIBITORS TO FUNCTIONALIZED POLYMERS
This document relates to conjugates of TNF inhibitors or derivatives thereof and functionalized (e.g., mono- or bi-functional) polymers (e.g., polyethylene...
2018/0369401 NOVEL PEPTIDIC LINKERS AND CRYPTOPHYCIN CONJUGATES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
The present disclosure relates to compounds of formula (I): RCG1-L-P (I) wherein RCG1 represents a reactive chemical group being reactive towards a chemical...
2018/0369400 NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND METHODS OF INDUCING EXON SKIPPING
Disclosed herein are molecules and pharmaceutical compositions that induce an insertion, deletion, duplication, or alteration in an incorrectly spliced mRNA...
2018/0369399 POLYMER CONJUGATES HAVING REDUCED ANTIGENICITY AND METHODS OF USING THE SAME
Disclosed herein are compositions and methods for reducing the antigenicity of molecules, wherein the molecule comprises a uricase. The antigenicity of a...
2018/0369398 METHODS FOR IMPROVED PROTECTION AND DELIVERY OF AMINOTHIOLS AND ANALOGS THEREOF
In one aspect, the present application relates to an aminothiol-conjugate of formula (I), wherein Core Linker R.sub.1, R.sub.2, R.sub.3, m, n, and p are as...
2018/0369397 POLYTHIOAMINALS AND USES THEREOF
Polythioaminal polymers are made from hexahydrotriazine precursors and dithiol precursors. The precursors are blended together and subjected to mild heating to...
2018/0369396 TARGETED SENSITIZATION OF NON-DEL(5q) MALIGNANT CELLS
Disclosed are molecules for treating non-del(5q) MDS that mimic allelic deficiency in del5q MDS to sensitize the malignant clones of patient without del(5q)....
2018/0369395 Halogenated Phenols for Diagnostics, Antioxidant Protection and Drug Delivery
The present invention provides compositions and methods for the targeted delivery, release and/or formation of a drug compound at a target site(s) within the...
2018/0369394 COLLOIDAL MICROCRYSTALLINE CELLULOSE COMPOSITIONS, THEIR PREPARATION AND PRODUCTS
The present invention is directed colloidal microcrystalline compositions, particularly for suspending particles in low viscosity fluids, produced by...
2018/0369393 COMPOSITION CONTAINING CATIONIC HYDROXYETHYL CELLULOSE
An aqueous solution comprising a cationic polymer dissolved in water, wherein said cationic polymer comprises a hydrophobic quaternary ammonium group...
2018/0369392 FAST DISSOLVING PHARMACEUTICAL COMPOSITION
The subject invention is directed to a pharmaceutical composition comprising an open matrix network carrying a pharmaceutically active ingredient, wherein the...
2018/0369391 HYDROGEL FOAMS AND METHODS OF MAKING AND USING THE SAME
The invention provides methods, compositions and kits relating to hydrogel foams.
2018/0369390 AQUEOUS SILICONE DISPERSIONS AND FILMS AND THEIR PREPARATION
An aqueous dispersion, useful for forming a film, comprises a silicone composition dispersed in an aqueous phase. The silicone composition comprises a product...
2018/0369389 NOVEL ANTICANCER PHARMACEUTICAL NANOFORMULATION AND METHOD OF PREPARING SAME
The present disclosure relates to a novel polymeric nano-formulation of a composition comprising an active ingredient and a polyethylene glycol ...
2018/0369388 PHARMACEUTICAL COMPOSITION
The present invention relates to a pharmaceutical composition comprising a solid dispersion of a drug. In the composition, the drug is in substantially...
2018/0369387 TRANSDERMAL CARRIER
Improved formulations for topical treatment that ensure at least localized transdermal or systemic delivery of an active agent through skin, nails or hair...
2018/0369386 LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS
This invention provides for a compound of formula (I): ##STR00001## or a pharmaceutically acceptable salt thereof, wherein R1-R4, L and X are defined herein. The...
2018/0369385 PSMA LIGANDS AND USES THEREOF
Compounds that are PSMA ligands, pharmaceutical compositions comprising these compounds, methods for treating and detecting cancers in a subject, methods for...
2018/0369384 COMPOSITIONS FOR NUCLEIC ACID DELIVERY
The present invention is based, in part, upon the discovery of charged lipids that provide advantages when used in lipid particles for the in vivo delivery of...
2018/0369383 FORMULATIONS OF BENDAMUSTINE
Methods of treatment using bendamustine formulations designed for small volume intravenous administration are disclosed. The methods conveniently allow shorter...
2018/0369382 GUIDED BONE REGENERATION MEMBRANE AND MANUFACTURING METHOD THEREOF
A guided bone regeneration material is disclosed. The guided bone regeneration material includes biodegradable fibers produced by an electrospinning method....
2018/0369381 VITAMIN D3 AND ANALOGS THEREOF FOR TREATING ALOPECIA
The invention provides methods and pharmaceutical compositions for preventing or treating alopecia, such as chemotherapy-induced alopecia (CIA). The...
2018/0369380 Methods and Compositions for Treating Conditions of the Eye
Provided are methods and compositions for treating ocular conditions characterized by the presence of unwanted choroidal neovasculature, for example,...
2018/0369379 NEOADJUVANT THERAPY FOR BLADDER CANCER
This invention relates to a neoadjuvant therapy for bladder cancer in bladder cancer patients who are scheduled for a cystectomy and methods of carrying out...
2018/0369378 Bacterial influence on regulation of appetite via ClpB protein mimicry of alpha-MSH
The present invention relates to CIpB expressing bacteria and their impact on obesity. The present invention relates to bacterial CIpB protein and CIpB...
2018/0369377 AQUEOUS PHARMACEUTICAL FORMULATION COMPRISING ANTI-PD-L1 ANTIBODY AVELUMAB
The present invention relates to a novel anti-PD-L1 antibody formulation. In particular, the invention relates to an aqueous pharmaceutical formulation of the...
2018/0369376 COMPOSITIONS AND METHODS FOR BETA-GLUCAN IMMUNOTHERAPY
This disclosure describes, in one aspect, a composition that includes a .beta.-glucan component and an antibody component that specifically binds to the...
2018/0369374 MRNA COMBINATION THERAPY FOR THE TREATMENT OF CANCER
The present disclosure relates to the use of nucleic acid (e.g., mRNA) combination therapies for the treatment of cancer. The disclosure provides compositions,...
2018/0369373 METHODS FOR DETECTING TISSUE INFILTRATING NK CELLS
The present invention relates to methods for detecting and monitoring NK cells in paraffin-embedded tissue samples. Also provided are antibodies, antibody...
2018/0369372 COMPOSITIONS AND METHODS OF TREATING SARCOMA LUNG METASTASIS
A method of treating pulmonary metastasis of osteosarcoma cells (pOSs) in a subject in need thereof includes administering to the subject a therapeutically...
2018/0369371 COMPOSITIONS AND METHODS FOR SELF-ADJUVANTING VACCINES AGAINST MICROBES AND TUMORS
The present invention is drawn to compositions and methods to enhance an immune response in order to prevent or treat infections or hyperproliferative diseases...
2018/0369370 LOW, IMMUNE ENHANCING, DOSE MTOR INHIBITORS AND USES THEREOF
The present invention relates, in part, to compositions and methods for enhancement of an immune response by partial mTOR inhibition, e.g., with low, immune...
2018/0369369 COMPOSITION COMPRISING ISCOM PARTICLES AND LIVE MICRO-ORGANISMS
Iscom particles can be used as an adjuvant for preparing of an antigenic composition which comprises live micro-organisms and/or killed micro-organisms and/or...
2018/0369368 QUIL A FRACTION WITH LOW TOXICITY AND USE THEREOF
Fraction A of Quil A can be used together with at least one other adjuvant for the preparation of an adjuvant composition, where the included adjuvant...
2018/0369367 Naturally-Occurring CpG Oligonucleotide Compositions and Therapeutic Applications Thereof
The present invention relates to combination therapies for the treatment of a variety of disorders in mammals, including hepatic disorders and cancer. The...
2018/0369366 METHODS AND COMPOSITIONS RELATED TO ACCELERATED HUMORAL AFFINITY
Disclosed herein is a vaccine comprising an antigen and a protein, peptide, or carbohydrate of Chlamydia spp., or a fragment thereof, wherein the antigen is...
2018/0369365 VACCINES AGAINST HERPES SIMPLEX VIRUS TYPE 2: COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE
Herpes Simplex Virus-2 (HSV-2) infection is a major health concern. The present disclosure provides, inter alia, certain highly effective vaccines and...
2018/0369364 RECOMBINANT VIRUS LIKE PARTICLES USING BOVINE IMMUNODEFICIENCY VIRUS GAG PROTEIN
Described herein, are Bovine immunodeficiency virus gag protein ("Bgag") recombinant virus like particles ("VLPs") including one or more different types of...
2018/0369363 Genetically Engineered Swine Influenza Virus And Uses Thereof
The present invention relates, in general, to attenuated swine influenza viruses having an impaired ability to antagonize the cellular interferon (IFN)...
2018/0369362 INFECTIOUS BRONCHITIS VIRUS VACCINE USING NEWCASTLE DISEASE VIRAL VECTOR
Provided are compositions and methods that involve recombinant Newcastle disease viruses (rNDVs), and recombinant vectors that encode them. The rNDVs comprise...
2018/0369361 Compositions and Methods for Vaccination Against Influenza a Virus
Disclosed herein are compositions and methods useful for immunizing a subject against disease caused by influenza A. Disclosed methods comprise administering...
2018/0369360 NOVEL TILAPIA VIRUS AND USES THEREOF
The invention is directed to isolated Tilapia Lake Virus or TiLV, and isolated nucleic acids sequences and polypeptides thereof. The invention also relates to...
2018/0369359 VIRUS PURIFICATION
Described herein are improved purification methods for virus vaccines and compositions. Also described are Zika, Chikungunya, dengue and yellow fever vaccines...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.